-
1
-
-
1642399711
-
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin VIa receptor knockout mice
-
Bielsky IF, Hu S-B, Szegda KL, Westphal H, Young LJ. 2004. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin VIa receptor knockout mice. Neuropsychopharmacology 29:483-493.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 483-493
-
-
Bielsky, I.F.1
Hu, S.-B.2
Szegda, K.L.3
Westphal, H.4
Young, L.J.5
-
2
-
-
0033082467
-
Multiple genes for neuropeptides and their receptors: Co-evolution and physiology
-
Darlison MC, Richter D. 1999. Multiple genes for neuropeptides and their receptors: co-evolution and physiology. TINS 22:81-88.
-
(1999)
TINS
, vol.22
, pp. 81-88
-
-
Darlison, M.C.1
Richter, D.2
-
4
-
-
0033006447
-
Vasopressin released within the septal brain area during swim stress modulates the behavioral stress response in rats
-
Ebner K, Wotjak CT, Holsboer F, Landgraf R, Engelmann M. 1999. Vasopressin released within the septal brain area during swim stress modulates the behavioral stress response in rats. Eur J Neurosci 11:997-1002.
-
(1999)
Eur J Neurosci
, vol.11
, pp. 997-1002
-
-
Ebner, K.1
Wotjak, C.T.2
Holsboer, F.3
Landgraf, R.4
Engelmann, M.5
-
5
-
-
0029787642
-
Behavioral consequences of intracerebral vasopressin and oxytocin: Focus on learning and memory
-
Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R. 1996. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 20:341-358.
-
(1996)
Neurosci Biobehav Rev
, vol.20
, pp. 341-358
-
-
Engelmann, M.1
Wotjak, C.T.2
Neumann, I.3
Ludwig, M.4
Landgraf, R.5
-
6
-
-
9944258456
-
The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: An old concept revisited
-
Engelmann M, Landgraf R, Wotjak CT. 2004. The hypothalamic- neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 25:132-149.
-
(2004)
Front Neuroendocrinol
, vol.25
, pp. 132-149
-
-
Engelmann, M.1
Landgraf, R.2
Wotjak, C.T.3
-
8
-
-
20644472668
-
Microsatellite instability generates diversity in brain and sociobehavioral traits
-
Hammock EA, Young LJ. 2005. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 308:1630-1634.
-
(2005)
Science
, vol.308
, pp. 1630-1634
-
-
Hammock, E.A.1
Young, L.J.2
-
9
-
-
0242352560
-
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
-
Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G. 2003. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24:580-588.
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 580-588
-
-
Holmes, A.1
Heilig, M.2
Rupniak, N.M.J.3
Steckler, T.4
Griebel, G.5
-
10
-
-
0034805457
-
Evolution of the nervous system. Evolution of vertebrate neuropeptides
-
Holmgren S, Jensen J. 2001. Evolution of the nervous system. Evolution of vertebrate neuropeptides. Brain Res Bull 55:723-735.
-
(2001)
Brain Res Bull
, vol.55
, pp. 723-735
-
-
Holmgren, S.1
Jensen, J.2
-
11
-
-
0037311629
-
Reduction in hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model
-
Keck ME, Welt T, Müller MB, Uhr M, Ohl F, Wigger A, Toschi N, Holsboer F, Landgraf R. 2003. Reduction in hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28:235-243.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 235-243
-
-
Keck, M.E.1
Welt, T.2
Müller, M.B.3
Uhr, M.4
Ohl, F.5
Wigger, A.6
Toschi, N.7
Holsboer, F.8
Landgraf, R.9
-
12
-
-
29544442910
-
Identification of glyoxalase-1 as a protein marker in a mouse model of extremes in trait anxiety
-
Krömer SA, Keßler MS, Milfay D, Birg IN, Bunck M, Czibere L, Panhuysen M, Pütz B, Denssing JM, Holsboer F, Landgraf R, Turck CW. 2005. Identification of glyoxalase-1 as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25:4387-4396.
-
(2005)
J Neurosci
, vol.25
, pp. 4387-4396
-
-
Krömer, S.A.1
Keßler, M.S.2
Milfay, D.3
Birg, I.N.4
Bunck, M.5
Czibere, L.6
Panhuysen, M.7
Pütz, B.8
Denssing, J.M.9
Holsboer, F.10
Landgraf, R.11
Turck, C.W.12
-
13
-
-
10444276636
-
Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication
-
Landgraf R, Neumann ID. 2004. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25:150-176.
-
(2004)
Front Neuroendocrinol
, vol.25
, pp. 150-176
-
-
Landgraf, R.1
Neumann, I.D.2
-
14
-
-
84855696517
-
Neuropeptides in anxiety modulation
-
Holsboer F, Ströhle A, editors. Berlin, Heidelberg: Springer
-
Landgraf R. 2005. Neuropeptides in anxiety modulation. In: Holsboer F, Ströhle A, editors. Anxiety and anxiolytic drugs. Handbook of experimental pharmacology, vol. 169. Berlin, Heidelberg: Springer, p 335-369.
-
(2005)
Anxiety and Anxiolytic Drugs. Handbook of Experimental Pharmacology
, vol.169
, pp. 335-369
-
-
Landgraf, R.1
-
15
-
-
29544441666
-
The involvement of the vasopressin system in stress-related disorders
-
in press
-
Landgrat R. 2006. The involvement of the vasopressin system in stress-related disorders. Curr Drug Target CNS Neurol Disord, in press.
-
(2006)
Curr Drug Target CNS Neurol Disord
-
-
Landgrat, R.1
-
17
-
-
4444325412
-
Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety
-
Murgatroyd C, Wigger A, Frank E, Singewald N, Bunck M, Holsboer F, Landgraf R, Spengler D. 2004. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J Neurosci 24:7762-7770.
-
(2004)
J Neurosci
, vol.24
, pp. 7762-7770
-
-
Murgatroyd, C.1
Wigger, A.2
Frank, E.3
Singewald, N.4
Bunck, M.5
Holsboer, F.6
Landgraf, R.7
Spengler, D.8
-
18
-
-
0030032350
-
Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
-
Purba JS, Hoogendijk WJ, Hoffman MA, Swaab DF. 1996. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53:137-143.
-
(1996)
Arch Gen Psychiatry
, vol.53
, pp. 137-143
-
-
Purba, J.S.1
Hoogendijk, W.J.2
Hoffman, M.A.3
Swaab, D.F.4
-
19
-
-
0027936468
-
Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
-
Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF. 1994. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444.
-
(1994)
Neuroendocrinology
, vol.60
, pp. 436-444
-
-
Raadsheer, F.C.1
Hoogendijk, W.J.G.2
Stam, F.C.3
Tilders, F.J.H.4
Swaab, D.F.5
-
20
-
-
11844286907
-
The central vasopressinergic system: Examining the opportunities for psychiatric drug development
-
Ring RH. 2005. The central vasopressinergic system: examining the opportunities for psychiatric drug development. Curr Pharm Des 11:205-225.
-
(2005)
Curr Pharm des
, vol.11
, pp. 205-225
-
-
Ring, R.H.1
-
21
-
-
0036830677
-
Vasopressin as a target for antidepressant development: An assessment of the available evidence
-
Scott LV, Dinan TG. 2002. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 72:113-124.
-
(2002)
J Affect Disord
, vol.72
, pp. 113-124
-
-
Scott, L.V.1
Dinan, T.G.2
-
23
-
-
11144356712
-
A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression
-
Van West D, Del-Favero J, Aulebenko Y, Oswald P, Sonery D, Forsgren T, Sluijs S, Bel-Kacem S, Adolfsson H, Mendlewicz J, Van Duijn C, Debontte D, Van Broeckhoven C, Claes S. 2004. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol Psychiatry 9:287-292.
-
(2004)
Mol Psychiatry
, vol.9
, pp. 287-292
-
-
Van West, D.1
Del-Favero, J.2
Aulebenko, Y.3
Oswald, P.4
Sonery, D.5
Forsgren, T.6
Sluijs, S.7
Bel-Kacem, S.8
Adolfsson, H.9
Mendlewicz, J.10
Van Duijn, C.11
Debontte, D.12
Van Broeckhoven, C.13
Claes, S.14
-
24
-
-
9144223849
-
Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: Critical role of vasopressin
-
Wigger A, Sánchez MM, Mathys KC, Ebner K, Liu D, Kresse A, Neumann ID, Holsboer F, Plotsky PM, Landgral R. 2004. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 29:1-14.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1-14
-
-
Wigger, A.1
Sánchez, M.M.2
Mathys, K.C.3
Ebner, K.4
Liu, D.5
Kresse, A.6
Neumann, I.D.7
Holsboer, F.8
Plotsky, P.M.9
Landgral, R.10
-
25
-
-
0029860680
-
Release of vasopressin within tie rat paraventricnlar nucleus in response to emotional stress: A novel mechanism of regulating adrenocorticotropic hormone secretion
-
Wotjak CT, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neumann I, Landgraf B. 1996. Release of vasopressin within tie rat paraventricnlar nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion. J Neurosci 16:7725-7732.
-
(1996)
J Neurosci
, vol.16
, pp. 7725-7732
-
-
Wotjak, C.T.1
Kubota, M.2
Liebsch, G.3
Montkowski, A.4
Holsboer, F.5
Neumann, I.6
Landgraf, B.7
|